COMPARATIVE EFFECTIVENESS OF DENOSUMAB VERSUS ORAL BISPHOSPHONATES AMONG POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS IN THE US MEDICARE PROGRAM

被引：0
|
作者：
Curtis, J. [1 ]
机构：
[1] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL USA
来源：
AGING CLINICAL AND EXPERIMENTAL RESEARCH | 2023年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
SY6
引用
收藏
页码：S580 / S580
页数：1
相关论文
共 50 条
  • [21] Denosumab versus bisphosphonates for treatment of postmenopausal osteoporosis: a meta-analysis
    Lan, Xiaoyong
    Ma, Haiping
    Zhang, Zhiping
    Ye, Dong
    Min, Jun
    Cai, Feng
    Luo, Jun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (09): : 11037 - 11048
  • [22] Indirect comparison of teriparatide, denosumab, and oral bisphosphonates for the prevention of vertebral and nonvertebral fractures in postmenopausal women with osteoporosis
    Zhang, Lanling
    Pang, Yafei
    Shi, Yeqing
    Xu, Meijuan
    Xu, Xia
    Zhang, Ju
    Ji, Lianmei
    Zhao, Dongbao
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2015, 22 (09): : 1021 - 1025
  • [23] Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
    Petranova, T.
    Boyanov, M.
    Shinkov, A.
    Petkova, R.
    Intorcia, M.
    Psachoulia, E.
    ARCHIVES OF OSTEOPOROSIS, 2017, 13 (01)
  • [24] Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
    T. Petranova
    M. Boyanov
    A. Shinkov
    R. Petkova
    M. Intorcia
    E. Psachoulia
    Archives of Osteoporosis, 2018, 13
  • [25] The efficacy and safety of denosumab in postmenopausal women with osteoporosis previously treated with bisphosphonates: A review
    Zhu, Yilin
    Huang, Zhonglian
    Wang, Yan
    Xu, Weicai
    Chen, Hongjiang
    Xu, Jiankun
    Luo, Shaowei
    Zhang, Yuantao
    Zhao, Di
    Hu, Jun
    JOURNAL OF ORTHOPAEDIC TRANSLATION, 2020, 22 : 7 - 13
  • [26] Factors Associated with Denosumab Initiation among Postmenopausal Osteoporosis Patients in Medicare
    Yun, Huifeng
    Chen, Rui
    Wright, Nicole C.
    Matthews, Robert
    Arora, Torun
    Milford, Ashley N.
    Xue, Fei
    Delzell, Elizabeth
    Curtis, Jeffrey R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 469 - 470
  • [27] MEDICATION-TAKING BEHAVIOUR IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS (OP) TREATED WITH DENOSUMAB OR MONTHLY ORAL BISPHOSPHONATES (OBPS)
    Petranova, T.
    Boyanov, M.
    Shinkov, A.
    Petkova, R.
    Psachoulia, E.
    VALUE IN HEALTH, 2015, 18 (07) : A650 - A651
  • [28] Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates
    P.D. Miller
    N. Pannacciulli
    J. Malouf-Sierra
    A. Singer
    E. Czerwiński
    H.G. Bone
    C. Wang
    S. Huang
    A. Chines
    W. Lems
    J.P. Brown
    Osteoporosis International, 2020, 31 : 181 - 191
  • [29] Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates
    Miller, P. D.
    Pannacciulli, N.
    Malouf-Sierra, J.
    Singer, A.
    Czerwinski, E.
    Bone, H. G.
    Wang, C.
    Huang, S.
    Chines, A.
    Lems, W.
    Brown, J. P.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (01) : 181 - 191
  • [30] Efficacy and safety of denosumab and teriparatide versus oral bisphosphonates to treat postmenopausal osteoporosis: a systematic review and meta-analysis
    Yang, Jia
    Guo, Xiaobo
    Cui, Zhongning
    Guo, Huikang
    Dong, Jia-Nan
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
12345